Erythema multiforme associated with gemfibrozil monotherapy.
BACKGROUND
A case of erythema multiforme associated with gemfibrozil monotherapy.


RESULTS
A 46-year-old man with hyperlipidemia was treated with 600 mg gemfibrozil twice a day. On the fifth day of treatment, skin lesions consistent with erythema multiforme appeared. With the discontinuation of the treatment and start of a topical steroid treatment, the lesions recovered after 4 weeks. After 6 months, when gemfibrozil therapy was restarted, lesions reappeared on the fourth day of therapy. Lesions recovered again following the previous treatment strategies after 4 weeks. An objective casualty assessment suggests that erythema multiforme was probably related to gemfibrozil monotherapy.


CONCLUSIONS
Patients starting gemfibrozil therapy should be warned about the occurrence of erythema multiforme in addition to previous reported and established side effects.
Yaçsar
Hamiyet Yilmaz
HY
Department of Endocrinology, Aydin State Hospital, Aydin, Turkey. drhamiyetyilmaz@yahoo.com
Ertuğrul
Ozden
O
Deniz
Coçskun
C
D004892:Erythema Multiforme / Q000139:chemically induced* / Q000175:diagnosis*; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
D015248:Gemfibrozil